Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2023 Nice Insight Reports
Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking
Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking
mRNA Vaccines & Therapeutics: 2023 Market Analysis, CDMO Pricing and Benchmarking
Sterile Drug Product: 2023 Market Analysis, CDMO Pricing and Benchmarking
Active Pharmaceutical Ingredients: 2023 Market Analysis, CDMO Pricing and Benchmarking
Antibody Drug Conjugates: 2023 Market Analysis, CDMO Pricing and Benchmarking
Contract Research Organizations: 2023 Market Analysis, Pricing and Benchmarking
Oral Solid Dosage: 2023 Market Analysis, CDMO Pricing and Benchmarking
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Influenza
23 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Osivax Receives Over EUR 30M in Public Funding to Support Development of Universal Coronavirus and Influenza Vaccines
PR-M07-20-NI-010
Immunotherapy
Applying the Principles of Immunotherapy to Infectious Diseases
PAP-Q2-20-CL-018
H1N1
Seaweed Extract Reduces Flu Severity
PR-M05-20-NI-018
Influenza
Bloomfield Hills Teen Awarded $25,000 for Developing Method to Create Universal Influenza Vaccine
PR-M08-19-NI-060
Influenza
Sanofi Signs Strategic Deal for Exclusive US Over-the-Counter Rights to Tamiflu® in Flu Care
PR-M07-19-NI-061
Influenza
Genentech’s Xofluza Flu Treatment Effective in Children
PAO-M07-19-NI-019
Influenza
GSK Ships 2019-20 Seasonal Influenza Vaccines for US Market
PR-M07-19-NI-047
Influenza Vaccine
Seqirus is First-to-Market with U.S. 2019/20 Influenza Vaccines
PR-M07-19-NI-045
Vaccines
Moderna Announces Publication of Phase 1 Data for mRNA Vaccines Against Two Potential Pandemic Influenza Strains
PR-M05-19-NI-041
FDA Approval
Genentech Receives FDA Approval for Flu Medicine
PAO-M11-18-NI-001
Influenza
Abbott Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results
PR-M10-18-NI-099
Influenza
Cell-Based Flu Vaccines Appear to Be More Effective than Egg-Based Strains
PAO-M10-18-NI-017
Influenza
FluMist Shipped by AstraZeneca
PAO-M10-18-NI-007
Collaboration
BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza
PR-M09-18-NI-052
Vaccines
GSK Ships 2018-19 Seasonal Influenza Vaccines for US Market
PR-M08-18-NI-110
Influenza
Brexit Issues Could Impact Flu Shot Deliveries to the UK
PAO-M08-18-NI-022
Influenza
Anti-Flu Drug Exploits Weakness in H3N2 Strain
PAO-M03-18-NI-021
Influenza
New BI Vaccine Allows Very Early Vaccination of Piglets Against Swine Flu
PAO-M03-18-NI-010
Influenza
GSK presents new efficacy data for FLUARIX® QUADRIVALENT (Influenza Vaccine) in children 6 months through 35 months of age
PR-M02-18-NI-87
Vaccine
GSK receives FDA approval for expanded indication for FLUARIX® QUADRIVALENT (Influenza Vaccine) for persons 6 months and older
PR-M01-18-NI-046
Capacity Expansion
Sanofi Expanding Manufacturing Capacity for Quadrivalent Influenza Vaccine
PAO-M10-17-NI-043
Drug Delivery
Recombinant Flu Vaccine Outperforms Egg-based Alternatives
PAO-M06-17-NI-019
Innovation
The Link Between Cancer and the Flu Virus
PAO-M05-17-NI-037
